Katharina Bell

First-in-human phase I study of ISTH0036, an antisense oligonucleotide selectively targeting transforming growth factor beta 2 (TGF-β2), in subjects with open-angle glaucoma undergoing glaucoma filtration surgery

Norbert Pfeiffer, Bogomil Voykov, Giulia Renieri et al. · PLoS ONE · 2017 · 67 citations · Full text

Age related retinal Ganglion cell susceptibility in context of autophagy deficiency

Katharina Bell, Ines Rosignol, Elena Sierra‐Filardi et al. · Cell Death Discovery · 2020 · 38 citations · Full text

The effect of pre-operative topical flurbiprofen or diclofenac on pupil dilatation

Vladimir Thaller, Mukul Kulshrestha, Katharina Bell · Eye · 2000 · 35 citations · Full text

Pupil Dilatation, Vitreous Body, Medicine +6

Neuroprotective effects of antibodies on retinal ganglion cells in an adolescent retina organ culture

Katharina Bell, Corina Wilding, Sebastian Funke et al. · Journal of Neurochemistry · 2016 · 31 citations · Full text

Ocular Disease, Immunology, Retinal Therapies +20

Serum and Antibodies of Glaucoma Patients Lead to Changes in the Proteome, Especially Cell Regulatory Proteins, in Retinal Cells

Katharina Bell, Sebastian Funke, Norbert Pfeiffer et al. · PLoS ONE · 2012 · 30 citations · Full text